Pegvisomant And Sandostatin LAR Combination Study

NCT00068029 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Pegvisomant/ Sandostatin LAR
DRUG: Sandostatin LAR
DRUG: Pegvisomant

Sponsor

Pfizer